Paola Barbieri Selected Research

roneparstat

1/2020	Roneparstat: Development, Preclinical and Clinical Studies.
1/2016	Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Barbieri Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 01/2004
1	Pathologic Constriction (Stenosis) 02/2020
1	Inflammation (Inflammations) 01/2020
1	Hyperpigmentation 11/2017
1	Infections 11/2017
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Mycosis Fungoides 03/2014
1	Starvation 11/2004
1	Cardiotoxicity 01/2004
1	Neutropenia 01/2004

Drug/Important Bio-Agent (IBA)

3	heparanaseIBA 01/2020 - 01/2016
2	roneparstatIBA 01/2020 - 01/2016
1	EnzymesIBA 01/2020
1	S100 Proteins (S 100 Protein)IBA 09/2018
1	CAM 5.2 antigenIBA 09/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2017
1	PhenazinesIBA 11/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2017
1	carfilzomibIBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Conditioned Culture MediaIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 10/2006
1	CarbonIBA 11/2004
1	NitrogenIBA 11/2004
1	Pharmaceutical PreparationsIBA 01/2004
1	BBR 3576IBA 01/2004
1	acivicin (AT 125)IBA 01/2004
1	anthrapyrazoleIBA 01/2004

Therapy/Procedure

2	Therapeutics 01/2016 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2016 - 01/2016
1	General Anesthesia 02/2020
1	Radiotherapy 03/2014
1	Photochemotherapy (Photodynamic Therapy) 10/2006